ET Alpha Wealth Summit to Address Portfolio Resilience and Alpha Generation in India Ajmera Realty Shares Surge 96 on Strong FY26 Financial Results Stocks Edge Lower on Oil Price Volatility and Middle East Peace Deal Uncertainty PMI Data Awaited Gas Prices Hit 455 Per Gallon Strategies for Consumers to Reduce Fuel Costs Ahead of Holiday Travel TD Cowen and RBC Capital Markets Adjust Home Depot Price Targets Following Solid Q1 Execution SEC Proposal Could Reshape Corporate Reporting Norms by Allowing OptOut of Quarterly Earnings SPH Q1 2026 Earnings EPS Surpasses Estimates as Propane Demand Holds Steady Medalist Diversified Inc MDRR Q2 2021 Earnings Earnings Beat Despite Negative EPS Stock Declines on Revenue Uncertainty SAH Q1 2026 Earnings EPS Beats Estimates by Nearly 15 Amid Solid Operational Execution CRGO Q4 2025 Earnings NarrowerthanExpected Loss Despite Macro Headwinds JILL Q1 2026 Earnings NarrowerLoss Beat Drives Modest Share Uptick EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates CocaCola KO Edges Higher as Stability Prevails Omega Healthcare Investors Slides 106 as Support Levels Come into Focus PSQ Holdings Inc PSQH Edges Higher as Bulls Test Key Resistance at 063 Cohu Inc COHU Surges Over 7 as Bullish Momentum Builds Regentis Biomaterials RGNT Holds Steady at 197 as Bulls Eye Breakout Above 207 Hindalco Shares Decline After 51 Drop in Q4 Net Profit Despite Revenue Growth Brokerages Offer Mixed Views VTEX Q1 2026 Earnings EPS Misses Estimates Amidst Market Skepticism Live Nation Entertainment Holds Steady Near Key Levels as Volumes Remain Subdued NGS Q1 2026 Earnings EPS Surprises to the Upside Amidst Solid Operational Execution PPHC Q4 2025 Earnings Strong EPS Beat Drives Stock Higher NRXS Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected AirJoule Technologies Corporation AIRJ Q1 2026 Earnings Deep Loss Surprises Market Yet Stock Climbs on Strategic Hopes Alamo Group Q1 2026 Earnings Strong EPS Beat Amid Steady Operational Execution Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment